Cargando…

Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence

Mucosa-associated invariant T (MAIT) cells play a critical role in antimicrobial defense. Despite increased understanding of their mycobacterial ligands and the clinical association of MAIT cells with tuberculosis (TB), their function in protection against Mycobacterium tuberculosis infection remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Dey, Ruchi Jain, Dey, Bappaditya, Harriff, Melanie, Canfield, Elizabeth T., Lewinsohn, David M., Bishai, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844931/
https://www.ncbi.nlm.nih.gov/pubmed/35164552
http://dx.doi.org/10.1128/mbio.03865-21
_version_ 1784651572769193984
author Dey, Ruchi Jain
Dey, Bappaditya
Harriff, Melanie
Canfield, Elizabeth T.
Lewinsohn, David M.
Bishai, William R.
author_facet Dey, Ruchi Jain
Dey, Bappaditya
Harriff, Melanie
Canfield, Elizabeth T.
Lewinsohn, David M.
Bishai, William R.
author_sort Dey, Ruchi Jain
collection PubMed
description Mucosa-associated invariant T (MAIT) cells play a critical role in antimicrobial defense. Despite increased understanding of their mycobacterial ligands and the clinical association of MAIT cells with tuberculosis (TB), their function in protection against Mycobacterium tuberculosis infection remains unclear. Here, we show that overexpressing key genes of the riboflavin-biosynthetic pathway potentiates MAIT cell activation and results in attenuation of M. tuberculosis virulence in vivo. Further, we observed greater control of M. tuberculosis infection in MAIT(hi) CAST/EiJ mice than in MAIT(lo) C57BL/6J mice, highlighting the protective role of MAIT cells against TB. We also endogenously adjuvanted Mycobacterium bovis BCG with MR1 ligands via overexpression of the lumazine synthase gene ribH and evaluated its protective efficacy in the mouse model of M. tuberculosis infection. Altogether, our findings demonstrate that MAIT cells confer host protection against TB and that overexpression of genes in the riboflavin-biosynthetic pathway attenuates M. tuberculosis virulence. Enhancing MAIT cell-mediated immunity may also offer a novel approach toward improved vaccines against TB.
format Online
Article
Text
id pubmed-8844931
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-88449312022-02-17 Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence Dey, Ruchi Jain Dey, Bappaditya Harriff, Melanie Canfield, Elizabeth T. Lewinsohn, David M. Bishai, William R. mBio Research Article Mucosa-associated invariant T (MAIT) cells play a critical role in antimicrobial defense. Despite increased understanding of their mycobacterial ligands and the clinical association of MAIT cells with tuberculosis (TB), their function in protection against Mycobacterium tuberculosis infection remains unclear. Here, we show that overexpressing key genes of the riboflavin-biosynthetic pathway potentiates MAIT cell activation and results in attenuation of M. tuberculosis virulence in vivo. Further, we observed greater control of M. tuberculosis infection in MAIT(hi) CAST/EiJ mice than in MAIT(lo) C57BL/6J mice, highlighting the protective role of MAIT cells against TB. We also endogenously adjuvanted Mycobacterium bovis BCG with MR1 ligands via overexpression of the lumazine synthase gene ribH and evaluated its protective efficacy in the mouse model of M. tuberculosis infection. Altogether, our findings demonstrate that MAIT cells confer host protection against TB and that overexpression of genes in the riboflavin-biosynthetic pathway attenuates M. tuberculosis virulence. Enhancing MAIT cell-mediated immunity may also offer a novel approach toward improved vaccines against TB. American Society for Microbiology 2022-02-15 /pmc/articles/PMC8844931/ /pubmed/35164552 http://dx.doi.org/10.1128/mbio.03865-21 Text en Copyright © 2022 Dey et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Dey, Ruchi Jain
Dey, Bappaditya
Harriff, Melanie
Canfield, Elizabeth T.
Lewinsohn, David M.
Bishai, William R.
Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence
title Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence
title_full Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence
title_fullStr Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence
title_full_unstemmed Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence
title_short Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence
title_sort augmentation of the riboflavin-biosynthetic pathway enhances mucosa-associated invariant t (mait) cell activation and diminishes mycobacterium tuberculosis virulence
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844931/
https://www.ncbi.nlm.nih.gov/pubmed/35164552
http://dx.doi.org/10.1128/mbio.03865-21
work_keys_str_mv AT deyruchijain augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence
AT deybappaditya augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence
AT harriffmelanie augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence
AT canfieldelizabetht augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence
AT lewinsohndavidm augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence
AT bishaiwilliamr augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence